|
|
| Name | Last | Chg |
|---|---|---|
| Dow Jones | 38700.57 |  1.24%
|
| NASDAQ | 16173.15 | 2.10%
|
All information above is at least 15 mins delayed.
Enter Symbol
|
|
| Name | Last | Chg |
|---|---|---|
| Dow Jones | 38700.57 | 1.24%
|
| NASDAQ | 16173.15 | 2.10%
|
| Symbol | Last | Chg |
|---|---|---|
| BENF | 8.0000 |
316.67%
|
| SGBX | 5.7300 |
95.56%
|
| ELYM | 11.1800 |
33.25%
|
| AIP | 7.8700 |
32.72%
|
| UPLD | 2.5899 |
28.21%
|
| Symbol | Last | Chg |
|---|---|---|
| MNDR | 4.4000 |
80.06%
|
| SPT | 30.0700 |
37.55%
|
| NUVO | 3.1000 |
34.18%
|
| UNIT | 4.7150 |
21.81%
|
| ZAPP | 2.0600 |
18.74%
|
| Symbol | Last | Chg |
|---|---|---|
| JAGX | 0.3191 |
8.83%
|
| SQQQ | 11.0599 |
6.11%
|
| AAPL | 185.6250 |
7.28%
|
| SGBX | 5.7300 |
95.56%
|
| NKLA | 0.6492 |
6.00%
|
For best results when printing this announcement, please click on link below:
/C O R R E C T I O N -- OSR Holdings/
PR Newswire
SEOUL, South Korea, April 22, 2024
In the news release, OSR Holdings and SillaJen have entered into a Memorandum
of Understanding to collaboratively pursue the development of innovative
therapeutics and enter the U.S. market, issued 22-Apr-2024 by OSR Holdings
over PR Newswire, we are advised by the company that in the 3rd paragraph,
"Dr. Seung-Hyun Choi" should read "Dr. Senyon Choe" as originally issued
inadvertently. The complete, corrected release follows:
OSR Holdings and SillaJen have entered into a Memorandum of Understanding to collaboratively pursue the development of innovative therapeutics and enter the U.S. market
Tae min Lee, taemin.lee@osr-holdings.com
Photo:
https://mma.prnewswire.com/media/2393302/OSR_Holdings_logo_Logo.jpg
Copyright (c) 2024 PR Newswire Association,LLC. All Rights Reserved.